Better Plant Sciences Inc

PINK:VEGGD USA Drug Manufacturers - Specialty & Generic
Market Cap
$199.18K
Market Cap Rank
#39466 Global
#12855 in USA
Share Price
$0.01
Change (1 day)
+0.00%
52-Week Range
$0.01 - $0.01
All Time High
$6.25
About

Better Plant Sciences Inc. offers financial accounting, bookkeeping, compliance, marketing, consulting, and other services. It provides corporate finance, director, and regulatory advisory services; and legal, accounting, and audit services. The company was formerly known as The Yield Growth Corp. and changed its name to Better Plant Sciences Inc. in August 2020. Better Plant Sciences Inc. was in… Read more

Better Plant Sciences Inc (VEGGD) - Net Assets

Latest net assets as of August 2023: $-2.21 Million USD

Based on the latest financial reports, Better Plant Sciences Inc (VEGGD) has net assets worth $-2.21 Million USD as of August 2023.

Net assets (also known as shareholders' equity or book value) represent the difference between a company's total assets ($191.27K) and total liabilities ($2.41 Million). This figure indicates the residual interest in the assets after deducting liabilities, essentially showing what would remain for shareholders if all assets were liquidated and all debts paid off.

Key Net Assets Metrics

Metric Value
Current Net Assets $-2.21 Million
% of Total Assets -1157.66%
Annual Growth Rate N/A
5-Year Change -161.06%
10-Year Change N/A
Growth Volatility 102.06

Better Plant Sciences Inc - Net Assets Trend (2017–2022)

This chart illustrates how Better Plant Sciences Inc's net assets have evolved over time, based on quarterly financial data. Explore and compare other companies by net assets.

Annual Net Assets for Better Plant Sciences Inc (2017–2022)

The table below shows the annual net assets of Better Plant Sciences Inc from 2017 to 2022.

Year Net Assets Change
2022-11-30 $-811.64K -155.91%
2021-11-30 $1.45 Million -55.74%
2020-11-30 $3.28 Million +156.43%
2019-11-30 $1.28 Million -3.77%
2018-11-30 $1.33 Million -50.98%
2017-11-30 $2.71 Million --

Equity Component Analysis

This analysis shows how different components contribute to Better Plant Sciences Inc's total equity over time. Equity components include common stock, retained earnings, additional paid-in capital, and other elements.

Equity Composition Insights

  • Retained earnings have decreased by 4023491200.0% over the analyzed period, potentially due to dividend distributions or operating losses.

Current Equity Component Breakdown (November 2022)

Component Amount Percentage
Common Stock $28.56 Million %
Other Comprehensive Income $10.83 Million %
Other Components $34.04K %
Total Equity $-811.64K 100.00%

Better Plant Sciences Inc Competitors by Market Cap

The table below lists competitors of Better Plant Sciences Inc ranked by their market capitalization.

Equity Growth Attribution

This analysis shows how different factors contributed to changes in Better Plant Sciences Inc's equity between the two most recent reporting periods.

Equity Growth Insights

  • From 2021 to 2022, total equity changed from 1,451,718 to -811,645, a change of -2,263,363 (-155.9%).
  • Net loss of 2,342,129 reduced equity.
  • Other comprehensive income increased equity by 78,766.
  • Other factors decreased equity by 0.

Equity Change Factors (2021 to 2022)

Factor Impact Contribution
Net Income $-2.34 Million -288.57%
Other Comprehensive Income $78.77K +9.7%
Total Change $- -155.91%

Book Value vs Market Value Analysis

This analysis compares Better Plant Sciences Inc's book value (net assets) with its market value over time. The relationship between these values can provide insights into investor sentiment and company valuation.

Valuation Insights

Historical Price-to-Book Ratios

Date Book Value per Share Market Price P/B Ratio
2015-11-30 $0.00 $0.01 x
2016-11-30 $0.00 $0.01 x
2017-11-30 $0.31 $0.01 x
2018-11-30 $0.15 $0.01 x
2019-11-30 $0.13 $0.01 x
2020-11-30 $0.28 $0.01 x
2021-11-30 $0.08 $0.01 x
2022-11-30 $-0.04 $0.01 x

Capital Efficiency Dashboard

This dashboard shows how efficiently Better Plant Sciences Inc utilizes its equity to generate returns, including Return on Equity (ROE) and its components based on the DuPont analysis framework.

Capital Efficiency Insights

  • Current Return on Equity (ROE): 0.00%
  • The company may be facing challenges in efficiently utilizing shareholder equity.
  • DuPont Analysis Breakdown:
  • • Net Profit Margin: -445.13%
  • • Asset Turnover: 0.37x
  • • Equity Multiplier: 0.00x
  • Recent ROE (0.00%) is above the historical average (-339.57%), indicating improving capital efficiency.

Historical Capital Efficiency Metrics

Year Return on Equity Net Profit Margin Asset Turnover Equity Multiplier Economic Value Added
2015 0.00% 0.00% 0.00x 0.00x $-25.20
2016 0.00% 0.00% 0.00x 0.00x $1.30
2017 -45.35% 0.00% 0.00x 1.03x $-1.50 Million
2018 -730.36% -317.73% 1.17x 1.97x $-9.84 Million
2019 -1365.79% -398.57% 1.17x 2.92x $-16.14 Million
2020 -238.01% -802.55% 0.24x 1.22x $-9.49 Million
2021 -337.04% -295.19% 0.49x 2.31x $-5.04 Million
2022 0.00% -445.13% 0.37x 0.00x $-2.26 Million

Industry Comparison

This section compares Better Plant Sciences Inc's net assets metrics with peer companies in the Drug Manufacturers - Specialty & Generic industry.

Industry Context

  • Industry: Drug Manufacturers - Specialty & Generic
  • Average net assets among peers: $548,450,613
  • Average return on equity (ROE) among peers: -450.37%

Peer Company Comparison

Company Net Assets Return on Equity Debt-to-Equity Market Cap
Better Plant Sciences Inc (VEGGD) $-2.21 Million 0.00% N/A $198.71K
Ascend Wellness Holdings Inc (AAWH) $142.87 Million -33.75% 5.44x $48.90 Million
AB Science S.A (ABSCF) $10.73 Million -252.65% 3.71x $39.89 Million
Alterola Biotech Inc (ABTI) $4.85K -2005.32% 0.49x $603.58K
Aurora Cannabis Inc (ACB) $2.04 Billion -34.08% 0.34x $199.15 Million
Acreage Holdings Inc (ACRDF) $204.27 Million -30.85% 1.41x $13.48K
Acura Pharmaceuticals Inc (ACUR) $7.90 Million -63.15% 1.15x $13.20K
Agra Ventures Ltd. (AGFAF) $1.51 Million -44.22% 0.06x $298.23K
Allergy Therapeutics plc (AGYTF) $2.07 Million -2084.75% 31.32x $25.30 Million
Aida Pharmaceuticals Inc (AIDA) $6.67 Million 24.51% 2.78x $1.80
Adcock Ingram Holdings Limited (AIHLF) $3.07 Billion 20.55% 0.55x $85.61 Million